UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents

The New England journal of medicine, 2014-12, Vol.371 (23), p.2155-2166

2014

Link zum Volltext

Verfügbarkeit prüfen

Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease

Journal of the American College of Cardiology, 2020-12, Vol.76 (22), p.2635-2646

2020

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODYSSEY COMBO I study

The American heart journal, 2015-06, Vol.169 (6), p.906-915.e13

2015

Link zum Volltext

Verfügbarkeit prüfen

Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease

The New England journal of medicine, 2015-11, Vol.373 (20), p.1905-1915

2015

Link zum Volltext

Verfügbarkeit prüfen

Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement

The New England journal of medicine, 2020-02, Vol.382 (9), p.799-809

2020

Link zum Volltext

Verfügbarkeit prüfen

Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention

JAMA : the journal of the American Medical Association, 2016-04, Vol.315 (16), p.1735

2016

Link zum Volltext

Verfügbarkeit prüfen

Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis

The Lancet (British edition), 2015-02, Vol.385 (9970), p.792-798

2015

Link zum Volltext

Verfügbarkeit prüfen

Safety and Efficacy of a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease, SAR236553/REGN727, in Patients With Primary Hypercholesterolemia Receiving Ongoing Stable Atorvastatin Therapy

Journal of the American College of Cardiology, 2012-06, Vol.59 (25), p.2344-2353

2012

Link zum Volltext

Verfügbarkeit prüfen

Bioresorbable Vascular Scaffolds for Coronary Revascularization

Circulation (New York, N.Y.), 2016-07, Vol.134 (2), p.168-182

2016

Link zum Volltext

Verfügbarkeit prüfen

1-year outcomes with the Absorb bioresorbable scaffold in patients with coronary artery disease: a patient-level, pooled meta-analysis

The Lancet (British edition), 2016-03, Vol.387 (10025), p.1277-1289

2016

Link zum Volltext

Verfügbarkeit prüfen

Lesion Complexity and Outcomes of Extended Dual Antiplatelet Therapy After Percutaneous Coronary Intervention

Journal of the American College of Cardiology, 2017-10, Vol.70 (18), p.2213-2223

2017

Link zum Volltext

Verfügbarkeit prüfen

Effect of Alirocumab, a Monoclonal Proprotein Convertase Subtilisin/Kexin 9 Antibody, on Lipoprotein(a) Concentrations (a Pooled Analysis of 150 mg Every Two Weeks Dosing from Phase 2 Trials)

The American journal of cardiology, 2014-09, Vol.114 (5), p.711-715

2014

Link zum Volltext

Verfügbarkeit prüfen

Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction

Journal of the American College of Cardiology, 2015-05, Vol.65 (20), p.2211-2221

2015

Link zum Volltext

Verfügbarkeit prüfen

Intracoronary ALLogeneic heart STem cells to Achieve myocardial Regeneration (ALLSTAR): a randomized, placebo-controlled, double-blinded trial

European heart journal, 2020-09, Vol.41 (36), p.3451-3458

2020

Link zum Volltext

Verfügbarkeit prüfen

Stent Thrombosis

Journal of the American College of Cardiology, 2010-10, Vol.56 (17), p.1357-1365

2010

Link zum Volltext

Verfügbarkeit prüfen

DAPT Score Utility for Risk Prediction in Patients With or Without Previous Myocardial Infarction

Journal of the American College of Cardiology, 2016-05, Vol.67 (21), p.2492-2502

2016

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of safety and efficacy of coronary intravascular lithotripsy for treatment of severely calcified coronary stenoses: Design and rationale for the Disrupt CAD III trial

The American heart journal, 2020-07, Vol.225, p.10-18

2020

Link zum Volltext

Verfügbarkeit prüfen

Autologous CD34+ Cell Therapy for Refractory Angina: 2-Year Outcomes from the ACT34-CMI Study

Cell transplantation, 2016-09, Vol.25 (9), p.1701-1711

2016

Link zum Volltext

Verfügbarkeit prüfen

Combining Antiplatelet and Anticoagulant Therapies

Journal of the American College of Cardiology, 2009-07, Vol.54 (2), p.95-109

2009

Link zum Volltext

Verfügbarkeit prüfen

Randomized Comparison of Everolimus- and Paclitaxel-Eluting Stents

Journal of the American College of Cardiology, 2011-06, Vol.58 (1), p.19-25

2011

Link zum Volltext

Verfügbarkeit prüfen

Meta-Analysis of Everolimus-Eluting Versus Paclitaxel-Eluting Stents in Coronary Artery Disease

JACC. Cardiovascular interventions, 2013-09, Vol.6 (9), p.914-922

2013

Link zum Volltext

Verfügbarkeit prüfen

Rationale and design of the EVOLVE Short DAPT Study to assess 3-month dual antiplatelet therapy in subjects at high risk for bleeding undergoing percutaneous coronary intervention

The American heart journal, 2018-11, Vol.205, p.110-117

2018

Link zum Volltext

Verfügbarkeit prüfen

Meta-Analysis of Trials on Mortality After Percutaneous Coronary Intervention Compared With Medical Therapy in Patients With Stable Coronary Heart Disease and Objective Evidence of Myocardial Ischemia

The American journal of cardiology, 2015-05, Vol.115 (9), p.1194-1199

2015

Link zum Volltext

Verfügbarkeit prüfen

Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions

The American heart journal, 2010-12, Vol.160 (6), p.1035-1041.e1

2010

Link zum Volltext

Verfügbarkeit prüfen

Atheroablation Imaging Insights

JACC. Cardiovascular interventions, 2023-09, Vol.16 (17), p.2137-2138

Kereiakes, Dean J.

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 745

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(721)
Mit Volltextzugriff
(700)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(447)
Science & Technology
(447)
Humans
(442)
Cardiovascular System & Cardiology
(385)
Cardiac & Cardiovascular Systems
(375)
Male
(259)
Female
(254)
Middle Aged
(212)
Biological And Medical Sciences
(206)
Medical Sciences
(205)
Treatment Outcome
(184)
Aged
(182)
Stents
(125)
Cardiology. Vascular System
(106)
Peripheral Vascular Disease
(95)
Time Factors
(91)
Cardiology
(87)
Cardiovascular
(83)
Heart
(82)
Platelet Aggregation Inhibitors - Therapeutic Use
(73)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents

Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease

Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODYSSEY COMBO I study

Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease

Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement

Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention

Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis

Safety and Efficacy of a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease, SAR236553/REGN727, in Patients With Primary Hypercholesterolemia Receiving Ongoing Stable Atorvastatin Therapy

Bioresorbable Vascular Scaffolds for Coronary Revascularization

1-year outcomes with the Absorb bioresorbable scaffold in patients with coronary artery disease: a patient-level, pooled meta-analysis

Lesion Complexity and Outcomes of Extended Dual Antiplatelet Therapy After Percutaneous Coronary Intervention

Effect of Alirocumab, a Monoclonal Proprotein Convertase Subtilisin/Kexin 9 Antibody, on Lipoprotein(a) Concentrations (a Pooled Analysis of 150 mg Every Two Weeks Dosing from Phase 2 Trials)

Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction

Intracoronary ALLogeneic heart STem cells to Achieve myocardial Regeneration (ALLSTAR): a randomized, placebo-controlled, double-blinded trial

Stent Thrombosis

DAPT Score Utility for Risk Prediction in Patients With or Without Previous Myocardial Infarction

Evaluation of safety and efficacy of coronary intravascular lithotripsy for treatment of severely calcified coronary stenoses: Design and rationale for the Disrupt CAD III trial

Autologous CD34+ Cell Therapy for Refractory Angina: 2-Year Outcomes from the ACT34-CMI Study

Combining Antiplatelet and Anticoagulant Therapies

Randomized Comparison of Everolimus- and Paclitaxel-Eluting Stents

Meta-Analysis of Everolimus-Eluting Versus Paclitaxel-Eluting Stents in Coronary Artery Disease

Rationale and design of the EVOLVE Short DAPT Study to assess 3-month dual antiplatelet therapy in subjects at high risk for bleeding undergoing percutaneous coronary intervention

Meta-Analysis of Trials on Mortality After Percutaneous Coronary Intervention Compared With Medical Therapy in Patients With Stable Coronary Heart Disease and Objective Evidence of Myocardial Ischemia

Atheroablation Imaging Insights

Suchergebnisse filtern